v2.4.0.8
Condensed Consolidated Statements of Cash Flows (USD $)
Share data in Millions, unless otherwise specified
 6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Cash flows from operating activities:    
Consolidated net income $ 17,500,000 $ 70,900,000
Adjustments to reconcile consolidated net income to net cash provided by (used in) operating activities:    
Depreciation 86,800,000 67,800,000
Amortization 37,400,000 32,500,000
Loss on redemption and other debt costs   78,500,000
Gain on acquisition of controlling interest   (23,500,000)
Long-lived asset impairment charges, net 700,000 2,600,000
Other non-cash items 9,600,000 8,100,000
Deferred income taxes (24,800,000) (10,800,000)
Change in operating assets and liabilities, and other (excluding effects of acquisition) (111,000,000) (260,900,000)
Net cash provided by (used in ) operating activities 16,200,000 (34,800,000)
Cash flows from investing activities:    
Capital expenditures (87,700,000) (55,600,000)
Acquisitions, net of cash acquired (5,800,000) 26,700,000
Proceeds from insurance recoveries and other 1,700,000  
Net cash used in investing activities (91,800,000) (28,900,000)
Cash flows from financing activities:    
Borrowings on ABL revolver 148,900,000 402,500,000
Repayments on ABL revolver (135,200,000) (297,300,000)
Issuance of long-term debt   450,000,000
Long-term debt payments (1,700,000) (530,400,000)
Lease financing obligation payment (2,300,000)  
Make-whole and other fees paid related to financing activities (600,000) (95,000,000)
Dividends paid (22,600,000) (5,600,000)
Distribution to noncontrolling interest (7,700,000) (13,300,000)
Excess tax benefits from share-based payment arrangements 2,000,000 700,000
Stock compensation plan activity (6,700,000) (1,300,000)
Net cash used in financing activities (25,900,000) (89,700,000)
Effect of exchange rate changes on cash and cash equivalents (2,300,000) (2,600,000)
Net change in cash and cash equivalents (103,800,000) (156,000,000)
Cash and cash equivalents at beginning of period 166,500,000 200,300,000
Cash and cash equivalents at end of period $ 62,700,000 $ 44,300,000